Charles S. Ence is the Chief Accounting and Compliance Officer (CAO) and Chief Operating Officer (COO) at Relmada Therapeutics, Inc. (RLMD), a clinical-stage biotechnology company focused on CNS disorders.( He joined Relmada in 2020, transitioning from CFO to his current CAO role while expanding financial operations.(

Ence brings extensive finance experience, including serving as CFO and Corporate Controller at New Age Beverages Corp. from 2003 to 2019, where he drove expansion to 46 U.S. states and 10 countries, ensured profitability, and led a NASDAQ uplisting.( Previously, he held senior roles at Quantum Corp. as Planning Manager and Director of Finance, Director of Finance and Investor Relations at On Command Corp., and spent 12 years at PepsiCo in financial analysis and controllership.( He holds a Bachelor of Arts in Business Administration and Accounting from Southern Utah University (1984) and an MBA in Finance from Arizona State University (1985).(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.